slides · global inventory
Size Opportunity
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,697
Current window 4,441-4,470
Pages 224
Rows per page 30
Slide function
4,441-4,470 of 6,697
05
The slide uses a funnel-like growth visualization to imply future market expansion beyond current launched indications.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Logic Chain1 hit
12
The slide uses a series of arrows to represent growth vectors. Data points are 6,000, 17,000, and 31,000.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · The Breakthrough1 hit
17
The slide uses a patient journey/treatment line framework to map clinical trials and market status against patient population segments.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a visual funnel/bridge metaphor to connect user growth to market size.Azerion | Results Presentation Deck | 24 slides · Azerion
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
04
Coupang | Results Presentation Deck | 28 slidesCoupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · Problem1 hit
08
The slide uses a combination of a ranked list and a stacked bar chart to illustrate market trends.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
11
The chart uses a waterfall-style additive visualization to reach a total TAM of $18.5B.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
12
The slide uses a waffle chart to represent individual brands and a pie chart to illustrate market penetration.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
10
The chart uses a broken x-axis to represent non-linear time intervals.DraftKings | Results Presentation Deck | 23 slides · DraftKings
Conference presentation Investor relations Beat · DevelopmentLoop · Quick Win Big Bet1 hit
18
The slide uses a structured comparison of four distinct disease areas to justify the market potential of the EQ101 franchise.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
29
The slide uses scientific citations to validate the mechanism of action (IL-21/IL-15) upstream of current therapies.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
13
Etsy | Results Presentation Deck | 46 slidesEtsy | Results Presentation Deck | 46 slides · Etsy
Conference presentation Investor relations Beat · Need1 hit
08
Uses a visual growth projection (circles) to represent market expansion.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
10
The slide uses a process flow diagram to map market segments to specific platform components.Freightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a grid-based layout to categorize product offerings under four main pillars, highlighting both current and potential future focus areas.Hims & Hers | Investor Presentation Deck | 41 slides · Hims & Hers
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
20
The slide uses a decomposition of total M&A transactions to isolate the mid-cap segment as the primary addressable market.Houlihan Lokey | Investor Presentation Deck | 34 slides · Houlihan Lokey
Pitch deck Investor relations 1 hit
20
The diagram shows a summation of ~29,712 (prevalence) and ~3,040 (derived from incidence) to reach ~32,752 eligible patients.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & Proof1 hit
21
The slide contrasts existing multi-drug combination therapies with the proposed monotherapy NXC-201.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & Proof1 hit
27
The slide uses a before-and-after visual comparison to illustrate market expansion.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Why Now1 hit
31
Includes a comparative table of clinical outcomes (ORR/CR/sCR) for NXC-201 vs. competitors.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
32
The slide uses a wave-like visual to represent market segments and their associated dollar values.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
41
Uses icon-based visualization to represent market expansion.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
48
The slide uses a bar chart to contrast the combined annual sales of two groups of oncology drugs.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
26
The slide contrasts the massive combined market of established CPIs ($42B) with the smaller market share of Libtayo ($0.5B) to frame the opportunity for partnership/growth.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
11
The chart visualizes the dominance of Alectinib and Crizotinib in the current market landscape.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
11
The chart visualizes the dominance of Alectinib and Crizotinib in the current market landscape.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
12
The slide uses a patient selection strategy based on ARID1a mutation status.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
The table segments indications by Squamous cell prevalence and NF2 mutation prevalence.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
07
South Plains Financial | Results Presentation Deck | 25 slidesSouth Plains Financial | Results Presentation Deck | 25 slides · South Plains Financial
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
12
The slide uses a combination of market sizing data and demographic behavioral data to justify a product launch.Talkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit